Publications by authors named "Toru Shibata"

Claim this Profile
A
ASO Visual Abstract: A Phase II Study of Short-Course Neoadjuvant Chemoradiotherapy with Gemcitabine, S-1, and Hypofractionated Radiotherapy for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma.
Hironobu Suto, Minoru Oshima, Yasuhisa Ando, Hiroyuki Matsukawa, Shigeo Takahashi, Toru Shibata

Ann Surg Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Study of Short-Course Neoadjuvant Chemoradiotherapy with Gemcitabine, S-1, and Hypofractionated Radiotherapy for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma.
Hironobu Suto, Minoru Oshima, Yasuhisa Ando, Hiroyuki Matsukawa, Shigeo Takahashi, Toru Shibata

Ann Surg Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy for cytokeratin-positive interstitial reticulum cell (CIRC) tumor on epicardium: a case report.
Masahide Anada, Haruyuki Fujita, Ryou Ishikawa, Shigeo Takahashi, Syunsuke Yoshida, Toru Shibata

Int Cancer Conf J· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of MLC error on dose distribution in SRS treatment of single-isocenter multiple brain metastases: comparison between DCAT and VMAT techniques.
Hiroki Katayama, Takuya Kobata, Motonori Kitaoka, Shigeo Takahashi, Toru Shibata

Rep Pract Oncol Radiother· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationships between postoperative recurrences and standardized uptake value on F-fluorodeoxyglucose-positron emission tomography in patients with resectable and borderline resectable pancreatic ductal adenocarcinoma who underwent curative pancreatic resection after neoadjuvant chemoradiotherapy.
Hironobu Suto, Mina Nagao, Hiroyuki Matsukawa, Takuro Fuke, Yasuhisa Ando, Toru Shibata

Pancreatology· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosimetric comparison of nodal clinical target volume for locally advanced non‑small cell lung cancer: Options for geometric expansion vs. lymph node stations.
Shigeo Takahashi, Masahide Anada, Toshifumi Kinoshita, Takamasa Nishide, Toru Shibata

Mol Clin Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short- and Long-Term Outcomes of Neoadjuvant Chemoradiotherapy Followed by Pancreatoduodenectomy in Elderly Patients with Resectable and Borderline Resectable Pancreatic Cancer: A Retrospective Study.
Hironobu Suto, Takuro Fuke, Hiroyuki Matsukawa, Yasuhisa Ando, Minoru Oshima, Toru Shibata

J Clin Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective study of locally advanced cervical cancer cases treated with CT-based 3D-IGBT compared with 2D-IGBT.
Toshifumi Kinoshita, Shigeo Takahashi, Masahide Anada, Takamasa Nishide, Kenji Kanenishi, Toru Shibata

Jpn J Radiol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avoiding Dosimetric Risk Factors for Complications in Neoadjuvant Chemoradiotherapy for Lung Cancer: Conventional Radiotherapy Intensity-modulated Radiotherapy.
Shigeo Takahashi, Masahide Anada, Toshifumi Kinoshita, Takamasa Nishide, Toru Shibata

Cancer Diagn Progn· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Prospective Study of Intensity-modulated Radiation Therapy Using a Standard Radiation Dose for High-grade Glioma.
Shigeo Takahashi, Keisuke Miyake, Daisuke Ogawa, Masahide Anada, Toshifumi Kinoshita, Toru Shibata

Cancer Diagn Progn· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of neoadjuvant chemoradiotherapy followed by pancreatic resection for older patients with resectable and borderline resectable pancreatic ductal adenocarcinoma.
Hironobu Suto, Minoru Oshima, Yasuhisa Ando, Hiroyuki Matsukawa, Shigeo Takahashi, Toru Shibata

HPB (Oxford)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the effect of high-density measurement mode on patient-specific quality assurance for head and neck cancer with ArcCHECK.
Hiroki Katayama, Yosuke Takahashi, Takuya Kobata, Hiroki Kawasaki, Motonori Kitaoka, Toru Shibata

Phys Eng Sci Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of local tumor control and recurrence-free survival in patients with pancreatic cancer undergoing curative resection after neoadjuvant chemoradiotherapy.
Hironobu Suto, Keiichi Okano, Minoru Oshima, Yasuhisa Ando, Hiroyuki Matsukawa, Toru Shibata

J Surg Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective Exploratory Study of the Relationship Between Radiation Pneumonitis and TGF-β1 in Exhaled Breath Condensate.
Shigeo Takahashi, Masahide Anada, Toshifumi Kinoshita, Takamasa Nishide, Toru Shibata

In Vivo· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Neoadjuvant Chemoradiation Therapy Administered for 5 Versus 2 Weeks for Resectable and Borderline Resectable Pancreatic Cancer.
Hironobu Suto, Keiichi Okano, Minoru Oshima, Yasuhisa Ando, Hiroyuki Matsukawa, Toru Shibata

Pancreas· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of rotational errors of whole pelvis on the dose of prostate-based image-guided radiotherapy to pelvic lymph nodes and small bowel in high-risk prostate cancer.
Hiroki Katayama, Shigeo Takahashi, Takuya Kobata, Akihiro Oishi, Toru Shibata

Rep Pract Oncol Radiother· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for hip dislocation in dyskinetic cerebral palsy.
Kyoko Okuno, Yukihiro Kitai, Toru Shibata, Hiroshi Arai

J Orthop Surg (Hong Kong)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Target coverage of daily cone-beam computed tomography in breath-hold image-guided radiotherapy for gastric lymphoma.
Shigeo Takahashi, Takamasa Nishide, Masato Tsuzuki, Hiroki Katayama, Masahide Anada, Toru Shibata

BJR Open· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of hippocampal dose-volume parameters associated with memory decline in intensity-modulated radiotherapy for supratentorial tumors.
Shigeo Takahashi, Masahide Anada, Toshifumi Kinoshita, Takamasa Nishide, Shohei Kozai, Toru Shibata

Mol Clin Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes and prognostic impact of inflammatory nutritional factors during neoadjuvant chemoradiotherapy for patients with resectable and borderline resectable pancreatic cancer.
Minoru Oshima, Keiichi Okano, Hironobu Suto, Yasuhisa Ando, Hideki Kamada, Toru Shibata

BMC Gastroenterol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy of target delineation by positron emission tomography-based auto-segmentation methods after deformable image registration: A phantom study.
Hiroki Katayama, Shigeo Takahashi, Yukito Maeda, Takuya Kobata, Akihiro Oishi, Toru Shibata

Phys Med· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of Pathological Complete Response With Tumor Volume Reduction During Neoadjuvant Chemoradiotherapy in Lung Cancer.
Shigeo Takahashi, Tetsuhiko Go, Masahide Anada, Toshifumi Kinoshita, Takamasa Nishide, Toru Shibata

Anticancer Res· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical evaluation of ID NOW influenza A & B 2, a rapid influenza virus detection kit using isothermal nucleic acid amplification technology - A comparison with currently available tests.
Keiko Mitamura, Hideaki Shimizu, Masahiko Yamazaki, Masataka Ichikawa, Takashi Abe, Toru Shibata

J Infect Chemother· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The predictors and patterns of the early recurrence of pancreatic ductal adenocarcinoma after pancreatectomy: the influence of pre- and post- operative adjuvant therapy.
Hironobu Suto, Keiichi Okano, Minoru Oshima, Yasuhisa Ando, Shigeo Takahashi, Toru Shibata

BMC Surg· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of combined modality therapy with sorafenib following hepatic arterial injection chemotherapy and three-dimensional conformal radiotherapy for advanced hepatocellular carcinoma with major vascular invasion.
Takako Nomura, Joji Tani, Akihiro Deguchi, Mai Nakahara, Kyoko Oura, Toru Shibata

Mol Clin Oncol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis